| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.6 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.6 |